ArticleClinical and translational medicine2025

IRF4 contributes to chemoresistance in IGH::BCL2-positive diffuse large B-cell lymphomas by mediating BCL2-induced SOX9 expression.

Yirong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.